News

AddToAny

Google+ Facebook Twitter Twitter

New leukaemia treatment for children

The NHS will be able to offer children a new cancer therapy labelled the “most exciting treatment advance for decades”.

CAR-T is for aggressive leukaemia and can be used when other drugs have failed. It typically costs hundreds of thousands of pounds per patient.

NHS England boss Simon Stevens says a fair and affordable price has been reached with manufacturer Novartis.

Hospitals could start giving it to a small number of children within weeks. The first three NHS hospitals to apply to use the CAR-T (which stands for “chimeric antigen receptor T-cell”) therapy are in London, Manchester and Newcastle.

The CAR-T treatment from Novartis has a list price of £282,000 per patient, though the actual figure NHS England will pay for it has not been disclosed.

The funding will come from the Cancer Drugs Fund, which aims to fast-track access to the most promising new cancer treatments.

 

Image credit | Science Photo Library 

Related Articles

How to… ensure effective blood stock management

Clare Denison and Fatts Chowdhury outline the Blood Stocks Management Scheme and explain how it can reduce wastage and save money.

Laboratory diagnostic test enters clinical practice

A blood test that improves the management pre-eclampsia has been introduced into routine practice, write Laboratory Manager Tim James and Consultant Obstetrician Manu Vatish.

Cutting-edge research pt.3

The IBMS has awarded five research grants this year. Here the final two successful candidates outline the work that they are undertaking.

Magnetic blood filtration

Medical device firm MediSieve was shortlisted for this year’s Hammersmith and Fulham Brilliant Business Awards.

Top